Farmax India Limited reported audited standalone and consolidated earnings results for the fourth quarter and full year ended March 31, 2014. For the quarter, the standalone company reported net income from operations of INR 42.324 million against INR 46.97 million a year ago. Profit from operations before other income and exceptional items was INR 5.02 million against loss from operations before other income and exceptional items of INR 116.04 million a year ago. Profit from ordinary activities before tax was INR 5.95 million against loss from ordinary activities before tax of INR 1,140.21 million a year ago. Net profit for the period was INR 5.951 million against net loss for the period of INR 1,147.44 million a year ago.

For the year, the standalone company reported net income from operations of INR 174.054 million against INR 519.235 million a year ago. Loss from operations before other income and exceptional items was INR 92.21 million against INR 243.713 million a year ago. Loss from ordinary activities before tax was INR 88.43 million against INR 1,265.924 million a year ago. Net loss for the period was INR 88.43 million against INR 1,273.152 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.22 against INR 3.55 a year ago.

For the year, the consolidated company reported net income from operations of INR 174.054 million against INR 519.235 million a year ago. Loss from operations before other income and exceptional items was INR 92.618 million against INR 244.082 million a year ago. Loss from ordinary activities before tax was INR 88.839 million against INR 1,437.567 million a year ago. Net loss for the period was INR 88.839 million against INR 1,444.795 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 4.03 against loss of INR 4.03 a year ago.